VESICARE LS Trademark

Trademark Overview

On Friday, January 27, 2017, a trademark application was filed for VESICARE LS with the United States Patent and Trademark Office. The USPTO has given the VESICARE LS trademark a serial number of 87315999. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 7, 2020. This trademark is owned by Astellas US LLC. The VESICARE LS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for the treatment of neurogenic detrusor overactivity
vesicare ls

General Information

Serial Number87315999
Word MarkVESICARE LS
Filing DateFriday, January 27, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 7, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparation for the treatment of neurogenic detrusor overactivity

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 31, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas US LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNorthbrook, IL 60062
Party NameAstellas US LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNorthbrook, IL 60062

Trademark Events

Event DateEvent Description
Tuesday, September 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 7, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, January 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 16, 2020EXTENSION 5 GRANTED
Tuesday, January 14, 2020EXTENSION 5 FILED
Thursday, January 16, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 14, 2020TEAS EXTENSION RECEIVED
Wednesday, June 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 24, 2019EXTENSION 4 GRANTED
Monday, June 24, 2019EXTENSION 4 FILED
Monday, June 24, 2019TEAS EXTENSION RECEIVED
Saturday, December 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 29, 2018EXTENSION 3 GRANTED
Thursday, November 29, 2018EXTENSION 3 FILED
Thursday, November 29, 2018TEAS EXTENSION RECEIVED
Friday, May 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 9, 2018EXTENSION 2 GRANTED
Wednesday, May 9, 2018EXTENSION 2 FILED
Wednesday, May 9, 2018TEAS EXTENSION RECEIVED
Friday, December 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 20, 2017EXTENSION 1 GRANTED
Wednesday, December 20, 2017EXTENSION 1 FILED
Wednesday, December 20, 2017TEAS EXTENSION RECEIVED
Tuesday, August 1, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 6, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 17, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 24, 2017ASSIGNED TO EXAMINER
Tuesday, January 31, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 31, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

vesicare detrusor overactivity neurogenic treatment preparation pharmaceutical